Anti-EMD monoclonal antibody

Pre-made anti-EMD monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to EMD/EMD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0758-Ab-1/ GM-Tg-hg-IP0758-Ab-2Anti-Human EMD monoclonal antibodyHuman
GM-Tg-rg-IP0758-Ab-1/ GM-Tg-rg-IP0758-Ab-2Anti-Rat EMD monoclonal antibodyRat
GM-Tg-mg-IP0758-Ab-1/ GM-Tg-mg-IP0758-Ab-2Anti-Mouse EMD monoclonal antibodyMouse
GM-Tg-cynog-IP0758-Ab-1/ GM-Tg-cynog-IP0758-Ab-2Anti-Cynomolgus/ Rhesus macaque EMD monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0758-Ab-1/ GM-Tg-felg-IP0758-Ab-2Anti-Feline EMD monoclonal antibodyFeline
GM-Tg-cang-IP0758-Ab-1/ GM-Tg-cang-IP0758-Ab-2Anti-Canine EMD monoclonal antibodyCanine
GM-Tg-bovg-IP0758-Ab-1/ GM-Tg-bovg-IP0758-Ab-2Anti-Bovine EMD monoclonal antibodyBovine
GM-Tg-equg-IP0758-Ab-1/ GM-Tg-equg-IP0758-Ab-2Anti-Equine EMD monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0758-Ab-1/ GM-Tg-hg-IP0758-Ab-2; GM-Tg-rg-IP0758-Ab-1/ GM-Tg-rg-IP0758-Ab-2;
GM-Tg-mg-IP0758-Ab-1/ GM-Tg-mg-IP0758-Ab-2; GM-Tg-cynog-IP0758-Ab-1/ GM-Tg-cynog-IP0758-Ab-2;
GM-Tg-felg-IP0758-Ab-1/ GM-Tg-felg-IP0758-Ab-2; GM-Tg-cang-IP0758-Ab-1/ GM-Tg-cang-IP0758-Ab-2;
GM-Tg-bovg-IP0758-Ab-1/ GM-Tg-bovg-IP0758-Ab-2; GM-Tg-equg-IP0758-Ab-1/ GM-Tg-equg-IP0758-Ab-2
Products NameAnti-EMD monoclonal antibody
Formatmab
Target NameEMD
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-EMD monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0758-Ag-1Recombinant multi-species EMD/ EDMD/ LEMD5 protein
    ORF Viral VectorvGMLP000693human EMD Lentivirus particle
    ORF Viral VectorpGMLP000693human EMD Lentivirus plasmid
    ORF Viral VectorpGMLPm002446mouse Emd Lentivirus plasmid
    ORF Viral VectorvGMLPm002446mouse Emd Lentivirus particle


    Target information

    Target IDGM-IP0758
    Target NameEMD
    Gene ID2010,13726,25437,699400,492249,101083409,399681,100059369
    Gene Symbol and SynonymsEDMD,EMD,LEMD5,STA
    Uniprot AccessionP50402,Q63190
    Uniprot Entry NameEMD_HUMAN,EMD_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000102119
    Target ClassificationN/A

    The target: EMD, gene name: EMD, also named as EDMD, LEMD5, STA. Emerin is a serine-rich nuclear membrane protein and a member of the nuclear lamina-associated protein family. It mediates membrane anchorage to the cytoskeleton. Dreifuss-Emery muscular dystrophy is an X-linked inherited degenerative myopathy resulting from mutation in the emerin gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.